Merck and Moderna initiate Phase 3 study evaluating V940 (mRNA-4157) in combination with Keytruda for treatment of non-small cell lung cancer

The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen therapy, V940 (mRNA-4157)

ExeGi Pharma announces first patient enrollment in the PROF Trial of EXE-346

First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes

Zepbound is now available in US for adults living with obesity

Express Scripts to add Zepbound to National Preferred Formulary

AbelZeta Pharma, AstraZeneca to co-develop a novel GPC3 armored CAR-T therapy in China

C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II

Mankind Pharma's PetStar ties up with Ranbir Kapoor and Neetu Kapoor for new campaign

The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets

Roche to acquire Carmot Therapeutics for US$ 2.7 billion

Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases

INEOS Styrolution’s NAS Eco cuts CO2 emissions by 93% in healthcare application

The new ECO grade is made using renewable feedstock

India Post, Apollo Cancer Centres Chennai to launch 'Stamp Out Childhood Cancer' campaign

Merck to acquire Caraway Therapeutics

Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases

Fosun Pharma USA and Treehill Partners to invest in biopharma space

The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market